Collateral for a security interest recorded Feb 27, 2018 (Biodesix, Inc.).
Term ended Mar 31, 2026 · High confidence
20-year base term ended Mar 31, 2026
Held by Biodesix Inc.
Filed Jan 20, 2009 as application 12/321,393 · Granted Jan 11, 2011
Base term, 20 years from filing
Today
Term ended Mar 31, 2026
2006
2026
Clock starts
Mar 31, 2006
Mar 31, 2006
Term ended
Mar 31, 2026
Mar 31, 2026
Granted
Jan 11, 2011
Jan 11, 2011
base term
after the term ends
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
20
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. All three maintenance fees were paid, so no fee lapse ended it. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 31, 2006, when application 11/396,328, the earliest non-provisional in its chain, was filed (this one was filed Jan 20, 2009) | Mar 31, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | Mar 31, 2026 | High confidence |
This family
| US 7,736,905 | In force Mar 2028 | Mar 2028 |
| Application PCT/US2007/007467 | PCT application no patent term | no patent term |
| US 8,024,282 | In force Feb 2028 | Feb 2028 |
| Application 61/191,927 | Provisional application no patent term | no patent term |
| US 7,858,390 | Lapsed on the fee record Dec 2022 | Dec 2022 |
| US 7,858,389 | Term ended no later than Jun 2026 | no later than Jun 2026 |
| US 7,867,775 | this patent Mar 2026 | Mar 2026 |
| US 7,906,342 | Term ended no later than May 2026 | no later than May 2026 |
8 of 20 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Mar 2, 2009 Reel 22348, frame 989 | Roder, Heinrich; Tsypin, Maxim; Grigorieva, Julia | Biodesix, Inc. | Assignment of Assignor's Interest |
| Dec 3, 2013 reel/frame not recorded | Biodesix, Inc. | Capital Royalty Partners II L.P. | Short-Form Patent Security Agreement |
| Dec 3, 2013 reel/frame not recorded | Biodesix, Inc. | Capital Royalty Partners II - Parallel Fund "a" L.P. | Short-Form Patent Security Agreement |
| Dec 3, 2013 reel/frame not recorded | Biodesix, Inc. | Parallel Investment Opportunities Partners II L.P. | Short-Form Patent Security Agreement |
| Dec 3, 2013 Reel 31751, frame 694 | Biodesix, Inc. | Capital Royalty Partners II L.P.; Capital Royalty Partners II - Parallel Fund "a" L.P.; Parallel Investment Opportunities Partners II L.P. | Short-Form Patent Security Agreement |
| Feb 5, 2018 Reel 44831, frame 24 | Roder, Heinrich; Tsypin, Maxim; Grigorieva, Julia | Biodesix Inc. | Assignment of Assignor's Interest |
| Feb 23, 2018 Reel 45022, frame 976 | Biodesix, Inc. | Innovatus Life Sciences Lending Fund I, LP, as Collateral Agent | Security Interest |
| Feb 27, 2018 Reel 45450, frame 503 | Capital Royalty Partners II L.P.; Capital Royalty Partners II - Parallel Fund "a" L.P.; Parallel Investment Opportunities Partners II L.P. | Biodesix, Inc. | Security Interest |
| Apr 12, 2018 Reel 45922, frame 171 | Capital Royalty Partners II L.P.; Capital Royalty Partners II - Parallel Fund "a" L.P.; Parallel Investment Opportunities Partners II L.P. | Biodesix, Inc. | Corrective Assignment to Correct the Nature of Conveyance Previously Recorded on Reel 045450 Frame 0503. Assignor(S) Hereby Confirms the Release of Security Interest. |
| Mar 19, 2021 Reel 55657, frame 911 | Innovatus Life Sciences Lending Fund I, LP, as Collateral Agent | Biodesix, Inc. | Release of Security Interest |
| Nov 22, 2022 Reel 61977, frame 919 | Biodesix, Inc. | Perceptive Credit Holdings IV, LP | Security Agreement |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
Citations
21
later US patents cite this one
That is above the median of utility patents granted in 2011 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.